Lpl Financial LLC Humacyte, Inc. Transaction History

Lpl Financial LLC

$218 Billion
Q3 2024

A detailed history of Lpl Financial LLC transactions in Humacyte, Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 511,992 shares of HUMA stock, worth $2.48 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

511,992

Previous 463,252 10.52%

Holding current value

$2.48 Million

Previous $2.22 Million 25.28%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$5.11 - $9.46 $249,061 - $461,080	48,740 Added 10.52%	511,992 $2.79 Million
Q2 2024 Aug 07, 2024	BUY	$2.87 - $9.1 $123,860 - $392,728	43,157 Added 10.27%	463,252 $2.22 Million
Q1 2024 May 10, 2024	BUY	$2.57 - $4.84 $135,053 - $254,342	52,550 Added 14.3%	420,095 $1.31 Million
Q4 2023 Feb 14, 2024	BUY	$1.99 - $3.12 $51,865 - $81,316	26,063 Added 7.63%	367,545 $1.04 Million
Q3 2023 Nov 13, 2023	BUY	$2.75 - $4.48 $69,690 - $113,532	25,342 Added 8.02%	341,482 $1 Million
Q2 2023 Jul 31, 2023	BUY	$2.86 - $4.97 $106,678 - $185,381	37,300 Added 13.38%	316,140 $904,000
Q1 2023 May 10, 2023	SELL	$2.11 - $3.25 $12,027 - $18,525	-5,700 Reduced 2.0%	278,840 $861,000
Q4 2022 Feb 07, 2023	SELL	$2.02 - $3.62 $57,570 - $103,170	-28,500 Reduced 9.1%	284,540 $600,000
Q3 2022 Nov 14, 2022	BUY	$1.22 - $5.14 $18,910 - $79,670	15,500 Added 5.21%	313,040 $1.02 Million
Q2 2022 Aug 12, 2022	BUY	$3.21 - $7.86 $955,103 - $2.34 Million	297,540 New	297,540 $955,000
Q1 2022 May 16, 2022	SELL	$4.65 - $7.4 $1.11 Million - $1.77 Million	-238,865 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$7.25 - $11.6 $900,812 - $1.44 Million	124,250 Added 108.41%	238,865 $1.73 Million
Q3 2021 Nov 15, 2021	BUY	$9.21 - $16.99 $1.06 Million - $1.95 Million	114,615 New	114,615 $1.33 Million

Others Institutions Holding HUMA

# of Institutions

150

Shares Held

35.1M

Call Options Held

279K

Put Options Held

607K

View Full List

About Humacyte, Inc.

Ticker HUMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,007,000
Market Cap $499M
Description
Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...

More about HUMA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Account

Lpl Financial LLC Humacyte, Inc. Transaction History